Roquefort Therapeutics plc (LON:ROQ)
London · Delayed Price · Currency is GBP · Price in GBX 1.550
-0.150 (-9.68%)
Jul 16, 2025, 4:35 PM BST
Roquefort Therapeutics Market Cap
Roquefort Therapeutics has a market cap or net worth of 2.44 million as of July 16, 2025. Its market cap has decreased by -60.22% in one year.
Market Cap
2.44M
Enterprise Value
2.50M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.55
Market Cap Chart
Since March 22, 2021, Roquefort Therapeutics's market cap has increased from 2.19M to 2.44M, an increase of 11.59%. That is a compound annual growth rate of 2.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2025 | 2.44M | -55.61% |
| Dec 31, 2024 | 5.50M | -41.29% |
| Dec 29, 2023 | 9.36M | 9.43% |
| Dec 30, 2022 | 8.56M | 13.33% |
| Dec 31, 2021 | 7.55M | 245.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 161.83B |
| GSK plc | 57.49B |
| Haleon | 32.34B |
| Smith & Nephew | 9.59B |
| ConvaTec Group | 4.94B |
| Hikma Pharmaceuticals | 4.35B |
| HUTCHMED (China) | 2.14B |
| Genus | 1.57B |